切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2018, Vol. 12 ›› Issue (05) : 354 -358. doi: 10.3877/cma.j.issn.1674-0793.2018.05.016

所属专题: 专题评论 文献

论著

保留乳头乳晕复合体乳腺癌术后脱细胞异体真皮辅助乳房再造的效果评价
杜露1, 丰锦春2, 吴涛2, 吐鲁洪·沙列尔2, 王斌2, 杨亮2, 赵倩2, 迪力夏提·金斯汗2, 许文婷2, 朱丽萍2,()   
  1. 1. 830011 乌鲁木齐,新疆医科大学附属肿瘤医院乳腺外科(一病区);830011 乌鲁木齐,新疆医科大学附属肿瘤医院特需科
    2. 830011 乌鲁木齐,新疆医科大学附属肿瘤医院乳腺外科(一病区)
  • 收稿日期:2017-12-09 出版日期:2018-10-01
  • 通信作者: 朱丽萍

Immediate breast reconstruction with acellular cadaveric dermis after nipple-areola complex–sparing mastectomy for breast cancer

Lu Du1, Jinchun Feng2, Tao Wu2, Shalie’er Tuluhong2, Bin Wang2, Liang Yang2, Qian Zhao2, Jinsihan Dilixiati2, Wenting Xu2, Liping Zhu2,()   

  1. 1. Department of Breast Surgery, Affiliated Cancer Hospital, Xinjiang Medical University, Urumqi 830011, China; Departmentof VIP, Affiliated Cancer Hospital, Xinjiang Medical University, Urumqi 830011, China
    2. Department of Breast Surgery, Affiliated Cancer Hospital, Xinjiang Medical University, Urumqi 830011, China
  • Received:2017-12-09 Published:2018-10-01
  • Corresponding author: Liping Zhu
  • About author:
    Corresponding author: Zhu Liping, Email:
引用本文:

杜露, 丰锦春, 吴涛, 吐鲁洪·沙列尔, 王斌, 杨亮, 赵倩, 迪力夏提·金斯汗, 许文婷, 朱丽萍. 保留乳头乳晕复合体乳腺癌术后脱细胞异体真皮辅助乳房再造的效果评价[J/OL]. 中华普通外科学文献(电子版), 2018, 12(05): 354-358.

Lu Du, Jinchun Feng, Tao Wu, Shalie’er Tuluhong, Bin Wang, Liang Yang, Qian Zhao, Jinsihan Dilixiati, Wenting Xu, Liping Zhu. Immediate breast reconstruction with acellular cadaveric dermis after nipple-areola complex–sparing mastectomy for breast cancer[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2018, 12(05): 354-358.

目的

对比保留乳头乳晕复合体乳腺癌术后即刻乳房再造术与脱细胞异体真皮辅助乳房再造术的近期疗效、不良反应及美容效果。

方法

前瞻性纳入2015年1月至2017年11月新疆医科大学附属肿瘤医院收治的需行乳房重建的乳腺癌患者59例,随机分为两组,其中保留乳头乳晕复合体乳腺癌术后即刻假体重建(对照组)28例,脱细胞异体真皮辅助的保留乳头乳晕复合体乳腺癌术后即刻假体重建(辅助组)31例,对比两组间的治疗效果、并发症及美容效果。

结果

所有患者成功完成乳房重建。对照组皮瓣坏死的发生率为21.4%(6/28),辅助组25.8%(8/31),两组间差异无统计学意义(χ2=0.156,P=0.693)。所有患者于术后6个月对乳房重建美容效果进行评价,辅助组优良率为86.7%(26/30),显著高于对照组的63.0%(17/27),差异有统计学意义(Z=-2.287,P=0.022)。术后对照组术区积液的发生率为28.6%(8/28),辅助组32.3%(10/31),差异无统计学意义(χ2=0.094,P=0.759);未出现过敏、排斥反应等其他并发症和不良反应。随访无患者发生肿瘤复发及转移。

结论

保留乳头乳晕复合体乳腺癌术后采用即刻乳房再造术与脱细胞异体真皮辅助乳房再造术假体重建方式效果相当,术后并发症方面没有明显差异,脱细胞异体真皮辅助乳房再造的美容效果相对较好。

Objective

To compare the short-term curative effect, complications and cosmetic result between immediate breast reconstruction and acellular cadaveric dermis-assisted immediate breast reconstruction after nipple-areola complex (NAC)–sparing mastectomy for breast cancer.

Methods

Between January 2015 and November 2017, a total of fifity-nine patients with breast cancer undergoing breast reconstruction in the Department of Breast Surgery, Affiliated Cancer Hospital, Xinjiang Medical University were included prospectively. Patients were randomly divided into two groups, 28 in the immediate breast reconstruction group (control group) and 31 in the acellular cadaveric dermis-assisted immediate breast reconstruction group (assisted group). The short-term curative effect, complications and cosmetic result between two groups were studied.

Results

All patients successfully completed the breast reconstruction. The incidence rate of skin flap necrosis of the control group was 21.4% (6/28), the assisted group 25.8% (8/31); there was no statistically significant difference between the two groups (χ2=0.156, P=0.693). All patients were evaluated the surgical results six months after the operation. The satisfaction rate of control group was 63.0% (17/27) and the assisted group was 86.7% (26/30) , with statistically significant difference (Z=-2.287, P=0.022). The incidence of seroma in the control group was 28.6% (8/28), and the assisted group 32.3% (10/31), with no statistically significant difference between the two groups (χ2=0.094, P=0.759). Other complications such as allergies and rejection did not occur.

Conclusion

Therapeutic effect and complications are similar between the two reconstruction methods without postoperation complication differences, but the cosmetic result of acellular cadaveric dermis-assisted immediate breast reconstruction group is better.

表1 两组乳腺癌患者术前基本资料的比较(例)
图1 脱细胞异体真皮(规格为4 cm×6 cm)对胸大肌缺损处进行修补
图3 辅助组术后6个月乳房再造效果(下皱襞切口)
图4 术后3周假体取出术中脱细胞异体真皮辅助的显示
[1]
吴炅,俞培荣. 乳腺癌术后乳房重建[M]. 北京: 人民卫生出版社,2016: 198-206.
[2]
卓睿,凌文津,石雪枫, 等.乳腺癌术后即时扩展型背阔肌肌皮瓣乳房重建27例分析[J/CD]. 中华乳腺病杂志(电子版), 2009,3(3):280-287.
[3]
金功圣,韩福生,王圣应, 等. 保留乳头乳晕复合体乳腺癌术后即时扩展型背阔肌肌皮瓣乳房再造[J]. 中国普通外科杂志, 2012,21(5):511-515.
[4]
卢伶俐,万能斌,周征宇, 等. 保留乳头乳晕的乳房全切术后带蒂大网膜联合假体乳房一期重建23例[J/CD]. 中华普通外科学文献(电子版), 2016,10(6):431-434.
[5]
蒋宏传,李发成,王克有, 等.乳腺癌改良根治术与乳房即时再造[J]. 中国微创外科杂志,2004,4(5):390-391.
[6]
Namnoum JD. Expander/implant reconstruction with AlloDerm: recent experience[J]. Plast Reconstr Surg, 2009,124(2):387-394.
[7]
Preminger BA, McCarthy CM, Hu QY, et al. The influence of AlloDerm on expander dynamics and complications in the setting of immediate tissue expander/implant reconstruction: A matched-cohort study[J]. Ann Plast Surg, 2008,60(5):510-513.
[8]
Buinewicz B, Rosen B. Acellular cadaveric dermis (Allo-Derm): A new alternative for abdominal hernia repair[J]. Ann Plast Surg, 2004,52(2):188-194.
[9]
Clemons JL, Myers DL, Aguilar VC, et al. Vaginal paravaginal repair with an AlloDerm graft[J]. Am J Obstet Gynecol, 2003,189(6):1612-1618.
[10]
Rohrich RJ, Reagan BJ, Adams WP Jr, et al. Early results of vermilion lip augmentation using acellular allogeneic dermis: An adjunct in facial rejuvenation[J]. Plast Reconstr Surg, 2000,105(1):409-416.
[11]
Wijayanayagam A, Kumar AS, Foster RD, et al. Optimizing the total skin-sparing mastectomy[J]. Arch Surg, 2008,143(1):38-45.
[12]
Reefy S, Patani N, Anderson A, et al. Oncological outcome and patient satisfaction with skin-sparing mastectomy and immediate breast reconstruction: a prospective observational study[J]. BMC Cancer, 2010,10:171.
[13]
王圣应,彭德峰,蔡兆根, 等. 早期乳腺癌乳头乳晕复合体隐匿癌浸润的临床病理研究[J]. 中华肿瘤杂志, 2008,30(3):203-206.
[14]
刘慧民. 探讨保留乳头乳晕乳腺癌改良根治术的方法及疗效[J]. 中国普通外科杂志, 2010,19(5):578-580.
[15]
雷岚,黄泽楠,姜华, 等. 保留乳头乳晕的乳腺癌改良根治术并Ⅰ期假体重建[J/CD]. 中华普通外科学文献(电子版), 2015,9(1):48-50.
[16]
杨青峰,张学,龚益平. 乳房切除即刻假体乳房再造的临床应用[J/CD]. 中华普通外科学文献(电子版), 2018,12(1):6-8.
[17]
Breuing KH, Warren SM. Immediate bilateral breast reconstruction with implants and inferolateral AlloDerm slings[J]. Ann Plast Surg, 2005,55(3):232-239.
[18]
Spear SL, Parikh PM, Reisin E, et al. Acellular dermis-assisted breast reconstruction[J]. Aesthetic Plast Surg, 2008,32(3):418-425.
[19]
蔡英,张亚男. 保留乳头乳晕复合体乳房切除术后复合体坏死的研究[J/CD]. 中华乳腺病杂志(电子版), 2014,8(5):361-364.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[3] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[4] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[5] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[6] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[7] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[8] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[9] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[10] 葛睿, 陈飞, 李杰, 李娟娟, 陈涵. 多基因检测在早期乳腺癌辅助治疗中的应用价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 257-263.
[11] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[12] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[13] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[14] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[15] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
阅读次数
全文


摘要